Compared to the use of cellular based technologies, gene editing, nanotech, and even more promising technologies ahead, the technology of ablation — the use of simple energy at various wavelengths, at various temperatures, intensities, methods desigend to be effective, accurate, and precise — is not as sexy, but these technologies really are medtech old school.
Indeed, ablation technologies may not be able to compete effectively against cell therapy, gene therapy, or other advanced medical technologies, especially where “cure” is a reality, but they really do stand at the forefront of surgery today (and in some sense as the likely peak of device technologies). They are not concepts or potential technologies, but are treating myriad diseases today, offering better outcomes and improving quality of lives and saving lives.
Growth rates in sales of devices, equipment, and supplies in most ablation types are at least respectable in an era of cost containment, while other ablation modalities are strong enough in tapping unmet patient demand that they are investment-attractive. Just as these technologies have emerged and developed alongside other MIS technologies, they will continue to track surgeries (or interventions, sorry cardio guys) and be there until surgery, interventional medicine, or whatever its moniker, is made obsolete.
See the Smithers Apex report, “The Future of Ablation Products to 2020,” described at link.
Source: Smithers Apex